Vesicular drug delivery for the treatment of topical disorders: current and future perspectives.


Journal

The Journal of pharmacy and pharmacology
ISSN: 2042-7158
Titre abrégé: J Pharm Pharmacol
Pays: England
ID NLM: 0376363

Informations de publication

Date de publication:
07 Oct 2021
Historique:
received: 02 02 2021
accepted: 12 05 2021
pubmed: 17 6 2021
medline: 27 1 2022
entrez: 16 6 2021
Statut: ppublish

Résumé

Vesicular drug delivery has become a useful approach for therapeutic administration of pharmaceutical compounds. Lipid vesicles have found application in membrane biology, immunology, genetic engineering and theragnostics. This review summarizes topical delivery, specifically dermal/transdermal, ocular and transungual, via these vesicles, including future formulation perspectives. Liposomes and their subsequent derivatives, viz. niosomes, transferosomes, pharmacososmes and ethosomes, form a significant part of vesicular systems that have been successfully utilized in treating an array of topical disorders. These vesicles are thought to be a safe and effective mode of improving the delivery of lipophilic and hydrophilic drugs. Several drug molecules are available for topical disorders. However, physicochemical properties and undesirable toxicity have limited their efficacy. Vesicular delivery systems have the potential to overcome these shortcomings due to properties such as high biocompatibility, simplicity of surface modification and suitability as controlled delivery vehicles. However, incorporating these systems into environmentally responsive dispersants such as hydrogels, ionic liquids and deep eutectic solvents may further enhance therapeutic prowess of these delivery systems. Consequently, improved vesicular drug delivery can be achieved by considering combining some of these formulation approaches.

Identifiants

pubmed: 34132342
pii: 6300436
doi: 10.1093/jpp/rgab082
doi:

Substances chimiques

Deep Eutectic Solvents 0
Drug Carriers 0
Lipids 0
Liposomes 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1427-1441

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Royal Pharmaceutical Society.

Auteurs

Bwalya A Witika (BA)

Division of Pharmaceutics, Department of Pharmacy, DDT College of Medicine, Gaborone, Botswana.

Larry L Mweetwa (LL)

Division of Pharmaceutics, Department of Pharmacy, DDT College of Medicine, Gaborone, Botswana.

Kabo O Tshiamo (KO)

Division of Pharmaceutics, Department of Pharmacy, DDT College of Medicine, Gaborone, Botswana.

Karen Edler (K)

Department of Chemistry, University of Bath, Bath, UK.

Scott K Matafwali (SK)

Department of Basic Sciences, School of Medicine, Copperbelt University, Ndola, Zambia.

Pascal V Ntemi (PV)

Department of Pharmaceutics, School of Pharmacy, Muhimbili University of Health Allied Sciences, Dar es Salaam, Tanzania.

Melissa T R Chikukwa (MTR)

Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, Makhanda, South Africa.

Pedzisai A Makoni (PA)

Division of Pharmacology, Faculty of Pharmacy, Rhodes University, Makhanda, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH